Alcohol use disorder (AUD) is the second highest preventable cause of death in France. Only 3% of patients are prescribed approved drugs for reducing alcohol consumption or maintenance of abstinence. Increasing evidence supports the efficacy of psychotherapies such as cognitive and behavioral therapies (CBT) in AUD. However, some patients are resistant to CBT and the positive effects of CBT could wane over time, resulting in mid- and long-term relapses. Mindfulness practice is increasingly widespread in the United States and its efficacy in various fields appears very promising. The study investigators hypothesize that the Mindfulness Based Relapse Prevention (MBRP) program will be more efficient than a relaxation/meditation without guidance control program in AUD.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
168
7 x 60-120 minute sessions with different themes: Automatic pilot/triggers/relapse/high-risk situations/ mindfulness in daily life. There will be a welcoming time, with a focus on at-home practice and difficulties, a theoretical presentation of new concepts, practical meditation exercises and a debriefing.
7 x 60-120 minute sessions each with a different sound from nature with unguided, closed relaxation group with a maximum of 12 participants
Ssra Les Eumenides
Angers, France
RECRUITINGHôpital Corentin-Celton
Issy-les-Moulineaux, France
NOT_YET_RECRUITINGCHU de Nantes
Nantes, France
RECRUITINGCHU de Nimes
Nîmes, France
RECRUITINGHopital Fernand Widal
Paris, France
NOT_YET_RECRUITINGHopital Des 4 Villes
Sèvres, France
NOT_YET_RECRUITINGHopital Paul Brousse
Villejuif, France
NOT_YET_RECRUITINGReduction in number of heavy drinking days (HDD) over previous 4 weeks, between the last drinking period at inclusion and 6 months.
Alcohol Time Line Follow Back (TLFB) where a HDD = consummation of 4+ (for women) or 5+ (for men) drinks per day.
Time frame: 6 months
Change in number of heavy drinking days (HDD) during the last 4 weeks, between the last drinking period at inclusion and 3 months between groups
Alcohol Time Line Follow Back (TLFB) where a HDD = consummation of 4+ (for women) or 5+ (for men) drinks per day.
Time frame: 3 months
Change in number of heavy drinking days (HDD) during the last 4 weeks, between the last drinking period at inclusion and 12 months between groups
Alcohol Time Line Follow Back (TLFB) where a HDD = consummation of 4+ (for women) or 5+ (for men) drinks per day.
Time frame: 12 months
Change in 4-week total alcohol consumption since baseline
number of drinks (1 glass = 1 unit according to grams alcohol)
Time frame: 3 months
Change in 4-week total alcohol consumption since baseline
number of drinks (1 glass = 1 unit according to grams alcohol)
Time frame: 12 months
Change in frequency of craving since baseline
version F of craving experience questionnaire (CEQ-F)
Time frame: 3 months
Change in frequency of craving since baseline
version F of craving experience questionnaire (CEQ-F)
Time frame: 6 months
Change in frequency of craving since baseline
version F of craving experience questionnaire (CEQ-F)
Time frame: 12 months
Change in strength of craving since baseline
version S of craving experience questionnaire (CEQ-S)
Time frame: 3 months
Change in strength of craving since baseline
version S of craving experience questionnaire (CEQ-S)
Time frame: 6 months
Change in strength of craving since baseline
version S of craving experience questionnaire (CEQ-S)
Time frame: 12 months
Anxiety at baseline
Beck Anxiety Inventory depression (BAI): 21-item self-assessment scale assessing anxiety
Time frame: Baseline
Change in anxiety since baseline
Beck Anxiety Inventory depression (BAI): 21-item self-assessment scale assessing anxiety
Time frame: 3 months
Change in anxiety since baseline
Beck Anxiety Inventory depression (BAI): 21-item self-assessment scale assessing anxiety
Time frame: 6 months
Change in anxiety since baseline
Beck Anxiety Inventory depression (BAI): 21-item self-assessment scale assessing anxiety
Time frame: 12 months
Depression at baseline
Beck Depression Inventory (BDI): 21 items assessing the presence and severity of depressive symptoms
Time frame: Baseline
Change in depression since baseline
Beck Depression Inventory (BDI): 21 items assessing the presence and severity of depressive symptoms
Time frame: 3 months
Change in depression since baseline
Beck Depression Inventory (BDI): 21 items assessing the presence and severity of depressive symptoms
Time frame: 6 months
Change in depression since baseline
Beck Depression Inventory (BDI): 21 items assessing the presence and severity of depressive symptoms
Time frame: 12 months
Change in quality of life since baseline
Alcohol Quality of Life Scale (AQoLS): 34-item patient-reported questionnaire
Time frame: 3 months
Change in quality of life since baseline
Alcohol Quality of Life Scale (AQoLS): 34-item patient-reported questionnaire
Time frame: 6 months
Change in quality of life since baseline
Alcohol Quality of Life Scale (AQoLS): 34-item patient-reported questionnaire
Time frame: 12 months
Emotion regulation at baseline
Emotion Regulation Questionnaire (ERQ): 10-item scale designed to assessing Cognitive Reappraisal and Expressive Suppression on a 7-point Likert-type scale ranging from 1 (strongly disagree) to 7 (strongly agree).
Time frame: Baseline
Change in emotion regulation since baseline
Emotion Regulation Questionnaire (ERQ): 10-item scale designed to assessing Cognitive Reappraisal and Expressive Suppression on a 7-point Likert-type scale ranging from 1 (strongly disagree) to 7 (strongly agree).
Time frame: 3 months
Change in emotion regulation since baseline
Emotion Regulation Questionnaire (ERQ): 10-item scale designed to assessing Cognitive Reappraisal and Expressive Suppression on a 7-point Likert-type scale ranging from 1 (strongly disagree) to 7 (strongly agree).
Time frame: 6 months
Change in emotion regulation since baseline
Emotion Regulation Questionnaire (ERQ): 10-item scale designed to assessing Cognitive Reappraisal and Expressive Suppression on a 7-point Likert-type scale ranging from 1 (strongly disagree) to 7 (strongly agree).
Time frame: 12 months
Difficulties regulating emotion at baseline
Difficulties in Emotion Regulation scale (DERS -Impulse): items 3, 14, 19, 24R, 27, 32 from DERS
Time frame: Baseline
Changes in difficulties regulating emotion since baseline
Difficulties in Emotion Regulation scale (DERS -Impulse): items 3, 14, 19, 24R, 27, 32 from DERS
Time frame: 3 months
Changes in difficulties regulating emotion since baseline
Difficulties in Emotion Regulation scale (DERS -Impulse): items 3, 14, 19, 24R, 27, 32 from DERS
Time frame: 6 months
Changes in difficulties regulating emotion since baseline
Difficulties in Emotion Regulation scale (DERS -Impulse): items 3, 14, 19, 24R, 27, 32 from DERS
Time frame: 12 months
Changes in impulsivity since baseline
Impulsive behavior scale (UPPS-P): 20-item self-assessment scale
Time frame: 3 months
Impulsivity at baseline
Impulsive behavior scale (UPPS-P): 20-item self-assessment scale
Time frame: Baseline
Changes in impulsivity since baseline
Impulsive behavior scale (UPPS-P): 20-item self-assessment scale
Time frame: 6 months
Changes in impulsivity since baseline
Impulsive behavior scale (UPPS-P): 20-item self-assessment scale
Time frame: 12 months
Changes in coping mechanism
brief COPE questionnaire: 14 scales including 2 items (28 items in total)
Time frame: 3 months
Coping mechanism at baseline
brief COPE questionnaire: 14 scales including 2 items (28 items in total)
Time frame: Baseline
Changes in coping mechanism
brief COPE questionnaire: 14 scales including 2 items (28 items in total)
Time frame: 6 months
Changes in coping mechanism
brief COPE questionnaire: 14 scales including 2 items (28 items in total)
Time frame: 12 months
Cognitive impairment
Montreal Cognitive Assessment (MoCA)
Time frame: Baseline
Initial mindfulness
Five Facets Mindfulness Questionnaire (FFMQ): 39-item self-assessment tool measuring 5 factors of mindfulness
Time frame: Baseline
Number of meditation sessions per week over the last 4 weeks
Time frame: Month 6
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.